Jeff Trotter is currently Senior Vice President – Worldwide Evidence for Worldwide Clinical Trials, one of the leading mid-sized contract research organizations, after Worldwide acquired the Late Stage research business unit from Continuum Clinical, a company Jeff co-founded in 2014. Formerly president of Continuum, a professional services company including capabilities in Late Stage Research, Patient Recruitment and Medical Communications, Jeff has enjoyed a diverse career in the healthcare industry spanning the past 30 years.
As an entrepreneur, researcher, consultant, and innovator, Jeff has been a pioneer in the evolving health economics and outcomes research community, and is an industry leader in the design and implementation of patient registries and observational studies. Jeff founded Ovation Research Group, an internationally known research and consulting firm (acquired by ICON Clinical Research), and has been in executive management with other research organizations (ICON, PharmaNet and inVentiv Health). He has spoken widely in front of varied industry audiences, and has published over 50 original articles and research papers – including a book for the American Hospital Association, The Quest for Cost-Effectiveness in Healthcare: Achieving Clinical Excellence While Controlling Cost. Jeff is a founding member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and holds a Master of Management (MBA) degree from Northwestern University’s Kellogg School of Management and a Bachelor’s degree in Accounting from the University of Illinois.